Xenon Pharmaceuticals
- Market cap
- 3.53B
- P/E (TTM)i
- -7.68
- P/Bi
- 2.84
- EPSi
- -4.36
- Div yieldi
- 0.00%
- 52W posi
- 2%
Anonymous reader poll. Unscientific, not investment advice.
Shares of Xenon Pharmaceuticals closed at 36.41, down 0.44%. At current prices, the business is worth about 3.53B, the #2361 most valuable US-listed company we track. Wall Street's 13-analyst consensus lands on Buy, with a price target averaging 74.00 (+103% from here). Over the past year the stock has ranged from 35.75 to 72.66; it now sits 2% up that band.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 weeks.
- Its last 6 Sell calls were actually followed by a +11% average gain three months out - this one has bounced back faster than the signal expected.
- Recent price momentum is -24.8% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 6.7% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 36.57
- Open
- 36.19
- Day range
- 35.78 - 36.56
- Avg price
- 36.28
- Volume
- 1.97M
- Turnover
- 71.38M
- Turnover ratei
- 2.16%
- Volume ratioi
- 0.78
- Amplitudei
- 2.13%
- 52-week rangei
- 35.75 - 72.66
Valuation
- P/Ei
- -8.35
- P/E (TTM)i
- -7.68
- P/Bi
- 2.84
- EPSi
- -4.36
- Book value / shi
- 12.83
- Net profit
- -422.22M
- Net assets
- 1.24B
Share structure
- Market cap
- 3.53B
- Float capi
- 3.31B
- Shares out
- 96.84M
- Float sharesi
- 90.90M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2015-04-02
49.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-12.12M net over the window
Short interest
- Shares short
- 6.44M
- % of floati
- 6.66%
- Days to coveri
- 12.22
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Xenon Pharmaceuticals (XENE)?
Xenon Pharmaceuticals last traded at 36.41. The quote on this page refreshes every few seconds while US markets are open.
What is Xenon Pharmaceuticals's market cap?
About 3.53B.
What is the P/E ratio of Xenon Pharmaceuticals?
The trailing twelve-month P/E is -7.68. The Valuation tab shows it against the stock's own five-year range.
Does Xenon Pharmaceuticals pay a dividend?
Xenon Pharmaceuticals does not currently pay a regular dividend.
Is Xenon Pharmaceuticals a buy according to analysts?
The consensus of 13 analysts is a Buy rating, with an average 12-month price target of 74.00, which implies 103.2% upside from the current price. This is not investment advice.
What is Xenon Pharmaceuticals's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Xenon Pharmaceuticals a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-08 08:29:12 · For reference only, not investment advice and not tailored to your situation.